ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1506

SLAMF6 Compartmentalization Regulates Autoimmune T Cell Responses

Yevgeniya Gartshteyn1, Anca Askanase2 and Adam Mor3, 1Columbia University Medical Center, Glen Rock, NJ, 2Columbia University Medical Center, New York, NY, 3CUIMC, New York, NY

Meeting: ACR Convergence 2021

Keywords: Cell-signalling molecules, Systemic lupus erythematosus (SLE), T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 9, 2021

Title: SLE – Etiology & Pathogenesis Poster (1480–1506)

Session Type: Poster Session D

Session Time: 8:30AM-10:30AM

Background/Purpose: T cell activation is initiated by engagement of the T cell receptor (TCR) complex and requires co-receptor signaling. SLAMF6 is a major T cell co-receptor and aberrant signaling downstream this receptor has have been implicated in the pathogenesis of systemic lupus erythematosus (SLE). Moreover, genome association studies in spontaneous murine lupus models of SLE associated SLAMF6 polymorphisms with loss of tolerance, autoantibody production, and susceptibility to SLE.

Accordingly, uncovering the mechanism of SLAMF6 signaling in autoimmune T cells could improve our understanding of the biology of SLE and could have translational therapeutic implications.

Methods: Activation of Jurkat T cells (ATCC) with 1) immobilized anti-CD3 and anti-SLAMF6 allowed for SLAMF6 clustering to the immunological synapse (IS) or 2) immobilized anti-CD3 and soluble anti-SLAMF6 resulted in exclusion of SLAMF6 from the IS. ELISA was used to measure cytokine secretion and CFSE assay to assess T cell proliferation. Co-immuno precipitation of SLAMF6 was performed using a SLAMF6 knock-out cell line that was transduced to express V5-tagged SLAMF6, results were analyzed using protein electrophoresis with immunoblotting and mass spectrometry.

SLAMF6 expression was evaluated in lymphocytes isolated from the peripheral blood of SLE patients with well characterized clinical phenotypes.

Results: Previously we discovered that SLAMF6 clustering is a requirement for its co-stimulatory functions. In the current work, we show that SLAMF6 recruitment to the immunological synapse (IS) is needed to support T cell proliferation and survival. Using confocal microscopy, we also show a direct correlation between SLAMF6 localization within the different compartments of the IS and the ability of this receptor to enhance secretion of multiple cytokines. Mechanistically, and through co-immunoprecipitation experiments, we reveal that SLAMF6 recruits several members of the Src family of kinases to IS, leading to enhance proximal phosphorylation of the TCR complex. Finally, taking advantage of Tfh cell isolated from patients with active SLE, we show that specific pharmacological interventions that prevent SLAMF6 clustering inhibit TCR signaling and multiple effector functions.

Conclusion: This transitional study advances the understanding of how SLAMF6 contribute to SLE pathogenesis, linking known SLE susceptible genes to specific signaling pathway in autoimmune T cells. Means to manipulate SLAMF6 signaling are promising approaches for novel SLE therapeutics.


Disclosures: Y. Gartshteyn, None; A. Askanase, GSK, 2, 5, AstraZeneca, 1, 5, Amgen, 1, Aurinia, 2, Abbvie, 1, Pfizer, 5, Eli Lilly, 5, Idorsia, 5; A. Mor, None.

To cite this abstract in AMA style:

Gartshteyn Y, Askanase A, Mor A. SLAMF6 Compartmentalization Regulates Autoimmune T Cell Responses [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/slamf6-compartmentalization-regulates-autoimmune-t-cell-responses/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/slamf6-compartmentalization-regulates-autoimmune-t-cell-responses/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology